The adjournment signals that management lacks sufficient votes to pass the Merger Agreement Proposal, despite a quorum. The reconvened meeting on October 15 is a binary catalyst — watch for last-minute proxy solicitation results and any further adjournments or announcements from the activist Celadon Partners.
Price Chart
Executive Summary
Senti Biosciences adjourned its 2026 Annual Meeting on October 8 without conducting business, despite a quorum being present, to allow more time to solicit votes for the Merger Agreement Proposal. The meeting is reconvened on October 15, 2026. The filing is a definitive additional proxy solicitation material filed by management, indicating ongoing activist pressure from Celadon Partners SPV 24 (per cross-filing context) and a contested vote on the merger proposal.
Key Financial Metrics
Key Facts
- The 2026 Annual Meeting was convened on October 8, 2026, and adjourned without conducting any business.
- A quorum was present at the meeting.
- The adjournment was to allow further time to solicit votes in favor of the Merger Agreement Proposal.
- The meeting will reconvene on Thursday, October 15, 2026, at 8:00 a.m. Pacific time.
- The record date remains September 23, 2026.
- No changes were made to the proposals to be voted on.
- Cross-filing context shows activist Celadon Partners SPV 24 has filed multiple SC 13D/A amendments (most recently on September 11, 2026) indicating an ongoing proxy fight.
Financial Impact
No financial figures disclosed in the filing. The outcome of the merger vote is binary and could determine the company's future structure.
Risk Factors
- The merger proposal may fail if management cannot secure enough votes by October 15.
- Activist Celadon Partners may be opposing the merger, increasing uncertainty.
- Further adjournments could prolong uncertainty and depress stock price.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001628280-26-065686 |
| Document: 0001628280-26-065686-index-headers.html | 0001628280-26-065686 |
| Document: 0001628280-26-065686-index.html | 0001628280-26-065686 |
| Document: 0001628280-26-065686.txt | 0001628280-26-065686 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $0.1720 | awaiting T+5 | — | $0.1690 (+1.74%) |
Oct 13, 2026 13d ago | DEFA14A | $0.2408 $0.2175 | ▼ −9.68% | ▼ −10.13% | $0.1690 (−29.82%) |
Oct 13, 2026 13d ago | 8-K | $0.2408 $0.2175 | ▲ +9.68% | ▲ +10.13% | $0.1690 (+29.82%) |
Sep 25, 2026 4w ago | EFFECT | $0.3293 $0.3223 | ▲ +2.13% | ▲ +1.90% | $0.1690 (+48.68%) |
Sep 24, 2026 4w ago | DEFM14A | $0.3293 $0.3223 | ▲ +2.13% | ▲ +1.90% | $0.1690 (+48.68%) |
Sep 22, 2026 5w ago | S-3/A | $0.3156 $0.3075 | ▲ +2.57% | ▲ +1.38% | $0.1690 (+46.45%) |
Sep 10, 2026 6w ago | S-3/A | $0.3060 $0.3200 | ▼ −4.58% | ▼ −4.80% | $0.1690 (+44.77%) |
Sep 4, 2026 7w ago | DEFA14A | $0.3326 $0.3021 | ▼ −9.17% | ▼ −7.96% | $0.1690 (−49.19%) |
Sep 4, 2026 7w ago | 8-K | $0.3326 $0.3021 | ▲ +9.17% | ▲ +7.96% | $0.1690 (+49.19%) |
Aug 20, 2026 9w ago | 8-K | $0.3886 $0.3770 | ▲ +2.99% | ▲ +3.46% | $0.1690 (+56.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers